Skip to main content
. 2009 Apr 16;106(18):7619–7623. doi: 10.1073/pnas.0902640106

Fig. 1.

Fig. 1.

CPHPC administration in Alzheimer's disease. CPHPC concentration in cerebrospinal fluid (A) and SAP concentrations in the plasma (B) and cerebrospinal fluid (C) in 5 patients with Alzheimer's disease are shown before, during, and after treatment with CPHPC for 12 weeks.